# Bernese Mountain Dog Health Problems: Malignant Histiocytosis and Elbow Dysplasia ## Key Takeaways - Malignant Histiocytosis (MH) is a systemic, rapidly progressive cancer of histiocytes, significantly overrepresented in Bernese Mountain Dogs, typically presenting in middle-aged to older dogs (4-7 years) with vague signs like lethargy, weight loss, and respiratory distress due to pulmonary infiltration. - Diagnosis of MH relies on advanced imaging (CT, MRI), cytology/histopathology of affected tissues (lymph nodes, masses), and bloodwork, with treatment primarily palliative chemotherapy due to a poor to grave prognosis. - Elbow Dysplasia (ED) is a common inherited developmental musculoskeletal disease in young Bernese Mountain Dogs (4-18 months), characterized by forelimb lameness, stiffness, and joint pain resulting from fragmented coronoid process, osteochondritis dissecans, ununited anconeal process, or incongruity. - Radiographs and CT scans are crucial for diagnosing ED, with treatment ranging from medical management (weight control, controlled exercise, NSAIDs) to surgical correction of specific lesions to mitigate progressive osteoarthritis. - Bernese Mountain Dogs exhibit a genetic predisposition to multiple orthopedic diseases, including ED and hip dysplasia, necessitating comprehensive orthopedic screening and management due to shared genetic pathways affecting joint development. - Early veterinary intervention is critical for both MH and ED; owners should seek immediate consultation for sudden lameness, progressive stiffness, unexplained lethargy, weight loss, or respiratory difficulties. --- Bernese Mountain Dogs are a beloved large breed, known for their striking tri-colored coats and gentle, loyal temperament. However, this breed carries a significant genetic burden. For owners and veterinarians, understanding the two most critical health problems is essential: **malignant histiocytosis**, a rapidly aggressive cancer, and **elbow dysplasia**, a debilitating developmental joint disease. This article provides a definitive, source-grounded overview of these conditions, offering a clear triage summary for owners, detailed clinical information for veterinary professionals, and evidence-based guidance for management. **Owner Triage Summary:** If your Bernese Mountain [Dog](/knowledge/veterinary-medicine/clinical-methods/dog) shows sudden, progressive lameness in a front leg (especially if they are a young adult), or develops unexplained lethargy, weight loss, or breathing difficulty (especially in middle age), seek veterinary attention immediately. Elbow dysplasia is a common cause of front-leg lameness in puppies and young adults. Malignant histiocytosis is a rapidly progressive cancer that can affect the lungs, lymph nodes, and other organs; early diagnosis is critical, but the prognosis is often poor. Do not attempt any home remedies; both conditions require professional diagnostic imaging and treatment. ## At a Glance: Comparing Malignant Histiocytosis and Elbow Dysplasia This table provides a quick clinical comparison for owners and general practitioners. It is not a substitute for a full veterinary workup. | Feature | Malignant Histiocytosis (MH) | Elbow Dysplasia (ED) | | :--- | :--- | :--- | | **Typical Age of Onset** | Middle-aged to older dogs (often 4-7 years) | Young dogs (often 4-18 months) | | **Primary System Affected** | Systemic (lungs, lymph nodes, spleen, liver, bone marrow, CNS) | Musculoskeletal (elbow joint) | | **Common Presenting Signs** | Lethargy, weight loss, inappetence, cough, difficulty breathing, swollen lymph nodes, sometimes lameness | Forelimb lameness that worsens with exercise, stiffness after rest, difficulty rising, "flipping" of the paw, swollen elbow joint | | **Underlying Cause** | Neoplastic proliferation of histiocytes (immune cells) | Abnormal development of the elbow joint due to genetic and environmental factors | | **Diagnostic Approach** | Advanced imaging (CT, MRI), fine needle aspirates, biopsy, blood work | Radiographs (X-rays) of the elbow, often requiring sedation; CT for complex cases | | **Treatment Goal** | Chemotherapy (often palliative), supportive care | Surgical correction (if applicable) or medical management (pain relief, joint support) | | **Prognosis** | Poor to grave; rapidly progressive | Variable; often manageable with early intervention, but can lead to chronic arthritis | ## Understanding the Bernese Mountain Dog Breed The Bernese Mountain Dog is a large, sturdy working breed originating from Switzerland. While they are wonderful companions, their genetic pool has been challenged. Breed-specific health concerns are a major topic for owners and breeders. Reproductive health data from Sweden indicates that the breed faces challenges in this area as well, with a median litter size of 6.00 and a whelping rate of 62% [1]. This lower reproductive efficiency can make it harder for breeders to select for other health traits, potentially perpetuating issues like the ones discussed below [1]. This context is vital: the breed's health is a complex interplay of genetics, reproduction, and environmental factors. ## Malignant Histiocytosis in Bernese Mountain Dogs Malignant histiocytosis (MH) is a devastating, rapidly progressive cancer that is significantly overrepresented in Bernese Mountain Dogs. It arises from the uncontrolled proliferation of histiocytes, which are a type of white blood cell that plays a role in the immune system. This is not a single tumor but a systemic disease that can infiltrate multiple organs simultaneously. ### What is Malignant Histiocytosis? In simple terms, MH is a cancer of the immune system's "cleanup cells." These cells, called histiocytes, normally help fight infection and remove cellular debris. In MH, these cells become malignant and multiply out of control, forming tumors in various organs. The most common sites for these tumors in Bernese Mountain Dogs are the lungs, lymph nodes, spleen, liver, and bone marrow. Because it is a systemic disease, it can be difficult to catch early and progresses very quickly. ### Causes and Risk Factors The exact cause of MH is not fully understood, but a strong genetic predisposition is widely accepted. The breed's genetic makeup makes it susceptible to this specific form of cancer. While the approved sources do not detail the specific genetic mutations, the breed's overall health challenges, including a limited gene pool and reproductive inefficiency, may contribute to the persistence of such a trait [1]. There are no known environmental or lifestyle factors that have been proven to cause MH; it is primarily considered a genetic disease. ### Clinical Signs and Symptoms The clinical signs of MH are often vague and non-specific, which can delay diagnosis. Owners should be alert to any combination of the following: - **Lethargy and Depression:** The dog may seem unusually tired and uninterested in activities. - **Weight Loss and Inappetence:** A noticeable decrease in appetite leading to weight loss is common. - **Respiratory Signs:** Coughing, difficulty breathing (dyspnea), or rapid breathing (tachypnea) are common because the lungs are a frequent site of tumor growth. - **Lymphadenopathy:** Swollen lymph nodes (glands) under the jaw, in front of the shoulders, or behind the knees. - **Lameness:** If the cancer spreads to the bone or joints, it can cause pain and lameness. - **Neurological Signs:** In some cases, if the central nervous system is affected, the dog may show seizures, incoordination, or changes in behavior. ### Veterinary Examination and Diagnostics If MH is suspected, a veterinarian will perform a thorough physical examination and may recommend several diagnostic tests. 1. **Physical Examination:** The vet will palpate the abdomen for organ enlargement, feel all the lymph nodes, and listen to the lungs for abnormal sounds. 2. **Bloodwork:** Complete blood count (CBC) and serum biochemistry may show anemia, low platelets, or elevated liver enzymes, but these are non-specific findings. 3. **Diagnostic Imaging:** Thoracic radiographs (chest X-rays) are crucial to look for lung masses. Abdominal ultrasound can evaluate the spleen and liver. Advanced imaging like CT (computed tomography) or MRI (magnetic resonance imaging) provides a more detailed view of the extent of the disease. 4. **Cytology and Histopathology:** The definitive diagnosis is made by examining cells or tissue. A fine needle aspirate (FNA) of a swollen lymph node or a lung mass can be performed. A biopsy (a larger tissue sample) may be needed for a definitive diagnosis. A pathologist will look for the characteristic malignant histiocytes. ### Evidence-Based Management and Treatment The treatment for MH is challenging. Because it is a systemic disease, surgery is rarely curative. The primary treatment is chemotherapy, which is often used with a palliative intent to slow the progression of the disease and improve the dog's quality of life. There is no cure for MH. The goal of treatment is to extend life with a good quality of life for as long as possible. Supportive care, including medications for nausea, pain, and breathing difficulties, is also important. ### Unsafe Home Remedies and What to Avoid There are no safe or effective home remedies for cancer. Owners should avoid giving any unproven supplements or alternative therapies without veterinary supervision. Some of these can interfere with chemotherapy drugs or cause organ damage. The most important thing an owner can do is to work closely with a veterinary oncologist to develop a treatment plan that is appropriate for their dog's specific situation. ### Prognosis for Malignant Histiocytosis The prognosis for a dog diagnosed with MH is poor to grave. The disease is rapidly progressive and often resistant to treatment. Survival times are typically short, often measured in weeks to a few months, even with aggressive chemotherapy. The focus of veterinary care is on maintaining the dog's comfort and quality of life for as long as possible. ## Elbow Dysplasia in Bernese Mountain Dogs Elbow dysplasia (ED) is a common, inherited developmental disease of the elbow joint. It is a significant cause of forelimb lameness in young, large-breed dogs, including the Bernese Mountain Dog. The condition is not a single disease but a spectrum of developmental abnormalities that lead to incongruity (mismatched joint surfaces) and arthritis. ### What is Elbow Dysplasia? Elbow dysplasia is an umbrella term for several developmental abnormalities that affect the elbow joint. The elbow is a complex joint formed by three bones: the humerus (upper arm), the radius, and the ulna (forearm). For the joint to function smoothly, these bones must fit together perfectly. In ED, this normal development is disrupted. The most common forms of ED include: - **Fragmented Coronoid Process (FCP):** A piece of the coronoid process (a small bony projection on the ulna) breaks off. - **Osteochondritis Dissecans (OCD):** A flap of cartilage in the joint fails to attach to the bone underneath. - **Ununited Anconeal Process (UAP):** A separate center of bone growth at the back of the elbow (the anconeal process) fails to fuse with the rest of the ulna. - **Elbow Incongruity:** The bones of the joint do not fit together properly, leading to abnormal wear and tear. ### Causes and Risk Factors Elbow dysplasia is primarily a genetic disease. The genes responsible for normal joint development are not working correctly, leading to the structural abnormalities. While genetics are the primary cause, environmental factors such as rapid growth, excessive weight, and inappropriate exercise during the puppy phase can exacerbate the severity of the condition. The breed's predisposition to joint issues is well-documented. In a study of canine hip dysplasia, a related orthopedic condition, Bernese Mountain Dogs were found to have a high prevalence of dysplasia, with one Polish clinic reporting that 46% of Bernese Mountain Dogs examined were affected [2]. This high prevalence of hip dysplasia in the breed suggests a broader musculoskeletal susceptibility that can also manifest as elbow dysplasia. ### Clinical Signs and Symptoms The clinical signs of ED typically appear in puppies and young dogs between 4 and 18 months of age. The most common sign is: - **Forelimb Lameness:** This is often intermittent and may worsen after exercise. The lameness can be subtle at first. - **Stiffness:** The dog may be stiff after getting up from a rest, especially in the morning. - **Difficulty Rising:** The dog may be reluctant to get up or may take a few steps to "warm out" of the stiffness. - **"Flipping" of the Paw:** To compensate for the pain, the dog may turn its paw outward (supinate) while walking. - **Swollen Elbow:** The elbow joint may appear swollen or feel thick when compared to the other leg. - **Reluctance to Exercise:** The dog may be less willing to play, run, or go for walks. It is important to note that some dogs with ED may not show obvious lameness until later in life, when the secondary arthritis becomes severe. ### Veterinary Examination and Diagnostics A veterinarian will perform a thorough orthopedic examination. This includes: 1. **Observation:** Watching the dog walk and trot to assess the lameness. 2. **Palpation:** Feeling the elbow joints for swelling, pain, and a reduced range of motion. The vet may also manipulate the joint to elicit a pain response. 3. **Radiographs (X-rays):** This is the primary diagnostic tool for ED. X-rays of both elbows are taken to look for signs of FCP, OCD, UAP, or incongruity. Sedation or anesthesia is usually required to get proper positioning. 4. **Advanced Imaging:** In some cases, a CT scan may be recommended to get a more detailed view of the joint, especially if the X-rays are inconclusive or for surgical planning. ### Evidence-Based Management and Treatment The treatment for ED depends on the severity of the condition, the age of the dog, and the specific type of abnormality present. - **Medical Management:** For dogs with mild lameness or those who are not good surgical candidates, medical management is an option. This includes: - **Weight Management:** Maintaining a lean body condition is crucial to reduce stress on the joint. - **Controlled Exercise:** Regular, low-impact exercise (like leash walks and swimming) to maintain muscle mass without over-stressing the joint. - **Pain Management:** Non-steroidal anti-inflammatory drugs (NSAIDs) and other pain relievers to manage discomfort. - **Joint Supplements:** While not a cure, supplements like omega-3 fatty acids and glucosamine may help support joint health. This should be discussed with a veterinarian. - **Surgical Management:** Surgery is often recommended for young dogs with specific lesions like FCP or UAP. The goal of surgery is to remove the loose fragment, repair the joint surface, and improve joint congruity. Surgery can slow the progression of arthritis and improve the dog's long-term comfort. ### Unsafe Home Remedies and What to Avoid Do not give your dog human pain relievers like ibuprofen or acetaminophen. These are toxic to dogs and can be fatal. Also, avoid over-supplementing with calcium or vitamin D, as this can worsen the development of the joint. Always consult with your veterinarian before starting any treatment or supplement regimen. ### Prognosis for Elbow Dysplasia The prognosis for ED is variable. With early diagnosis and appropriate management, many dogs can live comfortable, active lives. However, ED inevitably leads to osteoarthritis (degenerative joint disease) in the affected joint. The goal of treatment is to slow the progression of this arthritis and manage the associated pain. The long-term prognosis is generally better for dogs that undergo early surgical intervention for specific lesions, but even then, they will likely require lifelong management for arthritis. ## The Connection Between Hip and Elbow Dysplasia in the Breed It is important for owners to understand that a dog predisposed to one orthopedic issue is often at risk for another. The study by Aleksiewicz et al. highlighted the high prevalence of hip dysplasia in Bernese Mountain Dogs, with 46% of those examined in one clinic being affected [2]. This is a significant finding. Hip dysplasia is a separate condition from elbow dysplasia, but both are developmental orthopedic diseases common in large breeds. A dog with elbow dysplasia should also be screened for hip dysplasia, and vice versa. This comprehensive approach to orthopedic health is essential for managing a Bernese Mountain Dog's overall well-being. ## Limitations and When to Contact a Veterinarian This article provides a comprehensive overview of two major health problems in Bernese Mountain Dogs. However, it is crucial to understand its limitations. Breed-level information cannot predict the health of an individual dog. The information presented here is based on population-level data and clinical experience. It cannot tell you if your specific dog will develop these conditions, how severe they will be, or what the best course of action is for your pet. **Contact your veterinarian immediately if you observe any of the following red flags:** - **Sudden or severe lameness** in any leg. - **Progressive lameness** that does not improve with rest. - **Unexplained weight loss, lethargy, or loss of appetite.** - **Difficulty breathing, coughing, or increased respiratory effort.** - **Any new lump or swelling**, especially if it is growing rapidly. - **Signs of pain**, such as whining, panting, restlessness, or aggression when touched. Early intervention is critical for both malignant histiocytosis and elbow dysplasia. A prompt and accurate diagnosis from a licensed veterinarian is the first and most important step in managing these conditions. ## The Genetic and Breed-Level Context: Why Bernese Mountain Dogs Are Vulnerable To fully understand why malignant histiocytosis and elbow dysplasia cast such a long shadow over the Bernese Mountain Dog, it is necessary to look beyond the individual diseases and consider the breed's broader genetic landscape. The Bernese Mountain Dog is a relatively small gene pool, a consequence of historical bottlenecks and the breed's origins as a farm dog in the Swiss Alps. This limited genetic diversity means that deleterious recessive traits, once introduced, can spread more readily through the population. The breed's reproductive challenges, including a median litter size of 6.00 and a whelping rate of only 62%, compound this issue [1]. When a breed has lower reproductive efficiency, breeders have fewer puppies from which to select future breeding stock. This can inadvertently narrow the gene pool further and make it more difficult to select against health problems while also maintaining other desirable traits like temperament and conformation [1]. This genetic fragility is not merely an abstract concern; it has direct clinical implications. The high prevalence of hip dysplasia in the breed, with one Polish clinic reporting that 46% of Bernese Mountain Dogs examined were affected, points to a systemic susceptibility to developmental orthopedic disease [2]. This finding is not isolated to the hip joint. The same genetic pathways that govern cartilage development, bone growth, and joint congruity are shared across all diarthrodial joints. Therefore, a dog that inherits a predisposition to abnormal joint development is at risk for problems in multiple joints, including the elbow, stifle, and hock. For the veterinary clinician, this means that a thorough orthopedic examination of a Bernese Mountain Dog should never be limited to the presenting complaint. A dog presenting with forelimb lameness due to elbow dysplasia should be carefully evaluated for concurrent hip dysplasia, and vice versa. This comprehensive approach is not just good medicine; it is essential for the long-term welfare of a breed with such a high musculoskeletal disease burden [2]. Furthermore, the genetic factors that predispose to malignant histiocytosis are likely distinct from those that cause orthopedic disease, but they coexist within the same vulnerable genome. The breed's overall health challenges, including its reproductive inefficiency, may contribute to the persistence of the genetic traits that lead to histiocytic sarcoma [1]. This is a critical point for breeders. Selecting for one trait, such as good elbow conformation, without considering the broader genetic health of the individual, may inadvertently perpetuate other disease risks. Modern breeding strategies, including the use of estimated breeding values (EBVs) for orthopedic diseases and the careful tracking of cancer incidence in pedigrees, are essential tools. However, these strategies are only as good as the data they rely upon, and the breed's small population size makes this work challenging. For the owner, understanding this genetic backdrop helps explain why a breed with such a wonderful temperament can also be so challenging to keep healthy. It is not a failure of individual care but a reflection of a genetic legacy that requires vigilance and proactive management. ## Malignant Histiocytosis: A Deeper Dive into Pathogenesis and Clinical Presentation Malignant histiocytosis is often described as a systemic disease, but understanding what that means at a cellular level is crucial for grasping its aggressive nature. Histiocytes are a diverse group of cells derived from the bone marrow, including macrophages and dendritic cells. Their normal role is to patrol tissues, engulf pathogens and cellular debris, and present antigens to the immune system. In malignant histiocytosis, a neoplastic transformation occurs in these cells, leading to uncontrolled proliferation. Unlike a localized tumor that grows in one place, the malignant histiocytes in this disease have a strong tendency to disseminate widely, often involving multiple organ systems simultaneously or in rapid succession. The most common sites of involvement are the lungs, lymph nodes, spleen, liver, and bone marrow. This pattern of spread explains the often-vague clinical signs. A dog may present with a cough and increased respiratory effort because the lungs are infiltrated with tumor cells. Alternatively, the owner may notice lethargy and inappetence due to systemic illness, or the veterinarian may palpate enlarged lymph nodes or an enlarged spleen during a routine examination. In some cases, the disease can also affect the central nervous system, leading to seizures, ataxia, or behavioral changes. The rapid progression of this disease is one of its most defining features. A dog that appears mildly lethargic one week can be in severe respiratory distress the next. This speed of progression is a key reason why early diagnosis is so critical, even though the prognosis remains poor. The diagnostic workup for a suspected case of malignant histiocytosis requires a systematic approach. The initial step is always a thorough physical examination, with particular attention paid to palpation of all peripheral lymph nodes, abdominal palpation for organomegaly, and thoracic auscultation for abnormal lung sounds. However, physical examination alone is insufficient. Baseline bloodwork, including a complete blood count and serum biochemistry profile, is essential to assess the dog's overall health and to identify any paraneoplastic effects of the tumor. Common findings may include a non-regenerative anemia, thrombocytopenia, and elevated liver enzymes, though these are non-specific and can be seen in many other diseases. Diagnostic imaging is the next critical step. Thoracic radiographs are mandatory in any dog suspected of having malignant histiocytosis, as pulmonary metastases or primary lung masses are common. Abdominal ultrasound is also highly recommended to evaluate the spleen, liver, and abdominal lymph nodes. While these modalities are useful for identifying lesions, they cannot provide a definitive diagnosis. Advanced imaging, such as computed tomography (CT), offers a more detailed assessment of the extent of the disease and is particularly valuable for surgical planning if a solitary lesion is identified, although this is uncommon. The definitive diagnosis of malignant histiocytosis relies on cytology or histopathology. A fine needle aspirate of an enlarged lymph node or a mass can often yield a rapid preliminary diagnosis, but a core biopsy or excisional biopsy provides a more definitive histologic diagnosis. Immunohistochemistry is often used to differentiate malignant histiocytosis from other round cell tumors, such as lymphoma, which is crucial because the treatment protocols differ significantly. ## The Challenge of Treating Malignant Histiocytosis: Realistic Goals and Owner Expectations When an owner receives a diagnosis of malignant histiocytosis for their Bernese Mountain Dog, the emotional impact is profound. The veterinary team must be prepared to guide the owner through the complex decisions that follow, providing realistic expectations while also offering compassionate support. The first and most important message is that there is no cure for this disease. The goal of treatment is palliative, focused on slowing the progression of the cancer and maintaining the dog's quality of life for as long as possible. This is a difficult conversation, but it is essential for setting appropriate expectations and preventing the owner from pursuing futile, expensive, and potentially harmful interventions. Chemotherapy is the mainstay of treatment for systemic malignant histiocytosis. However, the response to chemotherapy is often poor, and the duration of response is typically short. The specific chemotherapeutic protocols used are beyond the scope of this article, but they generally involve a combination of drugs that target rapidly dividing cells. The veterinary oncologist will tailor the protocol to the individual dog, taking into account the extent of the disease, the dog's overall health, and the owner's financial and emotional resources. It is important for owners to understand that chemotherapy in veterinary medicine is generally better tolerated than in human medicine, as the doses are lower and the goal is quality of life rather than cure. However, side effects such as gastrointestinal upset and bone marrow suppression can still occur and must be managed proactively. In addition to chemotherapy, supportive care is a cornerstone of managing a dog with malignant histiocytosis. This includes medications to control nausea and vomiting, appetite stimulants to encourage eating, and pain management if the dog is uncomfortable. If the dog is experiencing respiratory difficulty, oxygen therapy may be needed, and in some cases, thoracocentesis may be performed to drain fluid or air from the chest cavity. The veterinary team should work closely with the owner to monitor the dog's quality of life and make adjustments to the treatment plan as the disease progresses. Owners should be encouraged to keep a daily log of their dog's appetite, energy level, and any signs of pain or distress. This information is invaluable for the veterinary team in making decisions about when to adjust medications or when it may be time to consider humane euthanasia. The decision to pursue chemotherapy is a personal one for each owner. Some owners will choose to pursue every available option, while others will prioritize comfort and quality of life over extending survival time. Both decisions are valid and should be supported by the veterinary team. The key is to provide the owner with accurate information about the likely outcomes, including the expected survival times, the potential side effects of treatment, and the financial costs involved. A referral to a board-certified veterinary oncologist is often recommended, as these specialists have the expertise and experience to manage the complexities of this disease. Ultimately, the goal is to ensure that the dog's remaining time is as comfortable and meaningful as possible, and that the owner feels supported and informed throughout the journey. ## Elbow Dysplasia: Understanding the Spectrum of Disease and Its Biomechanical Consequences Elbow dysplasia is not a single entity but a spectrum of developmental abnormalities that result in an incongruent and unstable elbow joint. To appreciate the clinical implications, it is helpful to understand the normal anatomy and biomechanics of the elbow. The elbow is a hinge joint formed by the articulation of three bones: the humerus (upper arm), the radius, and the ulna (forearm). The radius bears approximately 60% of the weight transmitted through the joint, while the ulna bears the remaining 40%. For the joint to function smoothly, the articular surfaces of these three bones must align perfectly. Any disruption in this alignment, no matter how subtle, leads to abnormal stress distribution, cartilage damage, and eventually, osteoarthritis. The four recognized forms of elbow dysplasia are fragmented coronoid process (FCP), osteochondritis dissecans (OCD), ununited anconeal process (UAP), and elbow incongruity. FCP is the most common form and involves a fracture or fragmentation of the medial coronoid process of the ulna. This fragment can become loose within the joint, causing pain and inflammation. OCD is a condition in which a flap of cartilage fails to attach to the underlying subchondral bone, typically affecting the medial humeral condyle. UAP is a failure of the anconeal process to fuse with the rest of the ulna, leading to instability of the joint. Elbow incongruity is a more subtle condition in which the radius and ulna do not grow at the same rate, resulting in a step-like mismatch in the joint surface. It is important to note that these conditions often occur in combination, and a dog may have both FCP and OCD, for example. The clinical signs of elbow dysplasia are directly related to the biomechanical abnormalities described above. The most common presenting complaint is forelimb lameness in a young dog, typically between 4 and 18 months of age. The lameness is often intermittent and may be more pronounced after exercise or first thing in the morning. Owners may also notice stiffness, difficulty rising, and a reduced willingness to play or exercise. A classic sign is the "flipping" of the paw, where the dog turns its paw outward to shift weight away from the painful medial aspect of the joint. On physical examination, the veterinarian may detect joint effusion, thickening of the joint capsule, and a decreased range of motion. Pain may be elicited on full flexion or extension of the joint, and crepitus (a grating sensation) may be felt in more advanced cases. The diagnosis of elbow dysplasia relies heavily on diagnostic imaging. Standard radiographs of both elbows are the first-line imaging modality. However, obtaining high-quality radiographs of the elbow is technically challenging and requires precise positioning, which usually necessitates sedation or general anesthesia. Even with good positioning, some lesions, particularly FCP, can be difficult to visualize on plain radiographs. This is where advanced imaging, particularly computed tomography (CT), has revolutionized the diagnosis of elbow dysplasia. CT provides a three-dimensional view of the joint and is far more sensitive than radiography for detecting subtle lesions such as FCP and incongruity. For this reason, many veterinary orthopedic surgeons recommend CT for any dog with suspected elbow dysplasia, especially if surgical intervention is being considered. Arthroscopy, a minimally invasive surgical technique, can also be used both to confirm the diagnosis and to treat certain lesions. ## Treatment Strategies for Elbow Dysplasia: From Medical Management to Surgical Intervention The treatment of elbow dysplasia is tailored to the individual dog, taking into account the specific type of lesion, the severity of the lameness, the age of the dog, and the owner's goals. The overarching objectives are to alleviate pain, improve joint function, slow the progression of osteoarthritis, and maintain the dog's quality of life. Treatment options fall into two broad categories: medical (conservative) management and surgical intervention. Medical management is often the first-line approach for dogs with mild lameness, for dogs that are not good surgical candidates, or for owners who prefer a non-surgical approach. The cornerstone of medical management is weight control. Maintaining a lean body condition is arguably the single most important factor in reducing stress on an arthritic joint. Excess body weight significantly increases the load on the elbow joint, accelerating cartilage wear and exacerbating pain. A controlled exercise program is also essential. The goal is to maintain muscle mass and joint mobility without over-stressing the joint. Low-impact activities such as leash walks, swimming, and underwater treadmill therapy are ideal. High-impact activities such as jumping, running, and playing fetch should be avoided. Pharmacologic pain management is another key component of medical therapy. Non-steroidal anti-inflammatory drugs (NSAIDs) are the mainstay of pain relief for osteoarthritis in dogs. These drugs reduce inflammation and provide significant pain relief, but they must be used with caution, as they can have side effects on the gastrointestinal tract, kidneys, and liver. Baseline bloodwork is recommended before starting NSAID therapy, and periodic monitoring is advised. Other analgesic options include gabapentin, which is often used for chronic neuropathic pain, and amantadine, an NMDA receptor antagonist that can be helpful in managing chronic pain. In addition to prescription medications, joint supplements such as omega-3 fatty acids, glucosamine, and chondroitin sulfate are commonly recommended. While the evidence for their efficacy is mixed, they are generally safe and may provide some benefit in supporting joint health. It is important to discuss any supplements with the veterinarian, as some can interact with medications or be contraindicated in certain conditions. Surgical intervention is often recommended for young dogs with specific lesions, particularly FCP and UAP. The goals of surgery are to remove loose fragments, repair or stabilize the joint, and improve joint congruity. For FCP, arthroscopic removal of the fragmented piece is the standard of care. This minimally invasive approach allows for direct visualization of the joint, confirmation of the diagnosis, and treatment of concurrent lesions. For UAP, surgical fixation of the anconeal process is often performed, although the prognosis is more guarded. In cases of severe elbow incongruity, more complex surgical procedures such as ulnar ostectomy or dynamic proximal ulnar osteotomy may be considered. These procedures aim to alter the growth of the radius and ulna to improve joint alignment. It is important to note that surgery does not cure elbow dysplasia. Even with successful surgery, the joint will never be completely normal, and osteoarthritis will inevitably develop. However, surgery can slow the progression of arthritis, reduce pain, and improve the dog's long-term function and comfort. ## The Long-Term Reality: Managing Osteoarthritis and Maintaining Quality of Life Regardless of the treatment approach chosen, the long-term reality for a dog with elbow dysplasia is the development of osteoarthritis. Osteoarthritis is a progressive, degenerative condition characterized by the breakdown of articular cartilage, inflammation of the joint lining, and the formation of new bone around the joint. This process is irreversible, and the goal of long-term management is to slow its progression and manage the associated pain and disability. This requires a lifelong commitment from the owner and a collaborative relationship with the veterinary team. A multimodal approach is the most effective strategy for managing osteoarthritis. This involves combining non-pharmacologic and pharmacologic therapies to address the multiple facets of the disease. Non-pharmacologic therapies include weight management, controlled exercise, physical rehabilitation, and environmental modifications. Physical rehabilitation, performed by a certified canine rehabilitation therapist, can include therapeutic exercises, manual therapy, and modalities such as therapeutic ultrasound, laser therapy, and extracorporeal shockwave therapy. These therapies can help improve muscle strength, joint mobility, and pain control. Environmental modifications, such as providing ramps for stairs, non-slip flooring, and orthopedic bedding, can also make a significant difference in a dog's comfort and mobility. Pharmacologic management of osteoarthritis typically involves the long-term use of NSAIDs, often on an as-needed basis or at the lowest effective dose. However, long-term NSAID use carries risks, and regular monitoring of liver and kidney function is essential. In recent years, newer therapies have emerged that offer additional options for managing osteoarthritis pain. These include monoclonal antibody therapy, which targets nerve growth factor, a key mediator of pain in osteoarthritis. This injectable therapy is administered monthly and can provide significant pain relief with a favorable safety profile. Other options include platelet-rich plasma (PRP) and stem cell therapy, which are regenerative medicine approaches that aim to modify the disease process rather than just manage symptoms. While the evidence for these therapies is still evolving, they may be considered in select cases. The owner's role in managing a dog with elbow dysplasia is paramount. Owners should be educated about the signs of pain and discomfort in dogs, which can be subtle and may include changes in behavior, activity level, and posture. They should be encouraged to keep a pain diary and to communicate regularly with their veterinarian about their dog's response to treatment. Regular recheck examinations, including radiographs to monitor the progression of arthritis, are important for adjusting the treatment plan over time. With diligent management, many dogs with elbow dysplasia can live comfortable, happy, and active lives for many years. The key is early diagnosis, proactive treatment, and a commitment to lifelong care. ## Preparing for the Veterinary Visit: What Owners Should Observe and Document The success of a veterinary consultation for a suspected health problem often depends on the quality of information the owner can provide. For both malignant histiocytosis and elbow dysplasia, the clinical signs can be vague and intermittent, making owner observations critically important. Before scheduling a veterinary appointment, owners should take the time to observe their dog carefully and document their findings. This preparation can help the veterinarian make a more accurate diagnosis and develop a more effective treatment plan. For a dog with suspected elbow dysplasia, the owner should pay close attention to the dog's gait. Is the lameness consistent, or does it come and go? Does it worsen after exercise or first thing in the morning? Does the dog appear stiff when rising from a rest? Does the dog hold its paw in an abnormal position, such as turning it outward? The owner should also note any swelling or thickening of the elbow joint compared to the other leg. Taking videos of the dog walking and trotting from different angles can be incredibly helpful, as the lameness may not be apparent during the veterinary examination due to the stress and excitement of the clinic environment. The owner should also be prepared to provide information about the dog's diet, exercise routine, and any supplements or medications they are currently giving. For a dog with suspected malignant histiocytosis, the owner should document any changes in appetite, energy level, and weight. Has the dog been eating less? Is it sleeping more than usual? Has there been any noticeable weight loss? The owner should also note any respiratory signs, such as coughing, rapid breathing, or difficulty breathing, and any swelling of the lymph nodes. It is also important to document the timeline of these signs. When did the owner first notice something was wrong? How has the dog's condition changed over time? This information can help the veterinarian assess the rate of progression, which is a key feature of malignant histiocytosis. Owners should also be prepared to discuss their dog's medical history, including any previous illnesses, surgeries, or medications. They should bring a list of all current medications and supplements, including the dosages. If possible, they should also bring any previous medical records, including radiographs or laboratory results. This information can help the veterinarian avoid unnecessary repeat testing and make more informed decisions. Finally, owners should be prepared to discuss their goals and concerns. What are their expectations for treatment? What are their financial constraints? What is their philosophy regarding quality of life versus quantity of life? Open and honest communication between the owner and the veterinarian is essential for developing a treatment plan that is both medically sound and aligned with the owner's values. ## Special Considerations for Puppies and Young Adults The management of elbow dysplasia in a growing puppy presents unique challenges and opportunities. The primary goal during the growth phase is to manage the clinical signs while allowing the dog to develop normally. This requires a delicate balance between rest and exercise. Excessive rest can lead to muscle atrophy and weight gain, while excessive exercise can exacerbate joint damage. A controlled exercise program, consisting of short, frequent leash walks on soft surfaces, is generally recommended. High-impact activities, such as jumping, running, and playing with other large dogs, should be strictly limited. Nutrition plays a critical role in the management of a growing puppy with elbow dysplasia. The goal is to promote slow, steady growth to minimize stress on the developing joints. This means feeding a high-quality, large-breed [puppy food](/knowledge/veterinary-medicine/nutrition/puppy-nutrition-selecting-the-right-food-for-growth-and-development) that is formulated to support controlled growth. These foods are typically lower in energy density and calcium than regular puppy foods, which helps to prevent rapid weight gain and skeletal abnormalities. Owners should be counseled against supplementing with additional calcium or vitamin D, as this can worsen joint development. The puppy should be kept at a lean body condition, with the ribs easily palpable but not visible. Regular weigh-ins are recommended to monitor growth and adjust food intake as needed. Surgical intervention in a growing puppy with elbow dysplasia requires careful timing. For conditions like FCP, surgery is often recommended as soon as the diagnosis is confirmed, to remove the loose fragment and prevent further cartilage damage. For UAP, the timing of surgery is more critical, as the anconeal process normally fuses with the ulna by about 5 to 6 months of age. If the diagnosis is made before this fusion occurs, surgical fixation may be attempted. However, if the diagnosis is made after fusion should have occurred, the prognosis is more guarded. The decision to pursue surgery in a growing puppy should be made in consultation with a board-certified veterinary surgeon who has experience with these procedures. It is also important to screen puppies with elbow dysplasia for other developmental orthopedic diseases, particularly hip dysplasia. As noted earlier, the Bernese Mountain Dog has a high prevalence of hip dysplasia, and a dog with one orthopedic problem is at increased risk for another [2]. A comprehensive orthopedic examination, including radiographs of the hips, is recommended for any puppy diagnosed with elbow dysplasia. Early detection of hip dysplasia allows for earlier intervention, which can improve the long-term prognosis. ## The Role of Breeder Screening and Responsible Breeding Practices While this article is primarily focused on the clinical management of malignant histiocytosis and elbow dysplasia, the role of breeders in reducing the incidence of these diseases cannot be overstated. Responsible breeders have a moral and ethical obligation to screen their breeding stock for heritable diseases and to make breeding decisions that prioritize the health and welfare of the breed. For elbow dysplasia, this involves screening all potential breeding dogs for the condition. The Orthopedic Foundation for Animals (OFA) and the Fédération Cynologique Internationale (FCI) both offer elbow screening programs. These programs involve radiographing the elbows and having them evaluated by a panel of experts who assign a grade based on the severity of the disease. Only dogs with normal elbows (grade 0 or 1) should be considered for breeding. For malignant histiocytosis, the situation is more complex. There is currently no genetic test for the disease, and the mode of inheritance is not fully understood. However, breeders can reduce the risk by carefully tracking the incidence of cancer in their pedigrees and avoiding breeding dogs that have produced offspring with malignant histiocytosis. Breeders should also be aware of the breed's overall health challenges, including its low reproductive efficiency, and should work to maintain genetic diversity within the breed [1]. This can be challenging, as it requires balancing the need to select for health traits with the need to avoid excessive inbreeding. The role of the veterinary profession in supporting responsible breeding practices is also important. Veterinarians can educate breeders about the importance of health screening and can perform the necessary examinations and radiographs. They can also provide guidance on interpreting the results of these screenings and on making breeding decisions. By working together, veterinarians and breeders can make a significant impact on the health of the Bernese Mountain Dog breed. It is a long-term endeavor, but the potential rewards, in terms of healthier, happier dogs, are immense. ## Prognosis and Quality of Life: Honest Conversations and End-of-Life Considerations The prognosis for malignant histiocytosis is poor to grave, and the prognosis for elbow dysplasia is variable but manageable. These two very different prognoses require very different conversations with owners. For malignant histiocytosis, the veterinary team must be honest about the likely outcome while also providing hope and support. The focus should be on maximizing the dog's quality of life for as long as possible. This may involve chemotherapy, supportive care, and frequent monitoring. The owner should be prepared for the possibility of rapid decline and should be encouraged to discuss their wishes regarding end-of-life care before a crisis occurs. Quality of life assessments are a valuable tool in managing a dog with a terminal illness like malignant histiocytosis. These assessments typically involve scoring the dog's appetite, energy level, mobility, and comfort. Owners can use a simple scale to rate each category, and the total score can help guide decisions about treatment and euthanasia. It is important for owners to understand that euthanasia is a humane and compassionate option when the dog's quality of life is poor and cannot be improved. The decision to euthanize a beloved pet is one of the most difficult decisions an owner will ever make, and the veterinary team should provide support and guidance throughout the process. For elbow dysplasia, the prognosis is generally more favorable, but it is important to set realistic expectations. The dog will likely develop osteoarthritis, and lifelong management will be required. However, with appropriate treatment, many dogs can live comfortable, active lives for many years. The owner should be prepared for the financial and emotional commitment involved in managing a chronic condition. Regular veterinary checkups, medications, and potential physical rehabilitation are all part of the long-term plan. The veterinary team should work with the owner to develop a comprehensive management plan that addresses the dog's physical, emotional, and behavioral needs. By taking a proactive and collaborative approach, it is possible to help a dog with elbow dysplasia live a full and happy life. ## Frequently Asked Questions ### What is the life expectancy of a Bernese Mountain Dog with malignant histiocytosis? The prognosis is poor to grave; survival time is typically short, often only weeks to a few months even with aggressive chemotherapy, as the disease is rapidly progressive and often resistant to treatment. ### At what age does elbow dysplasia typically appear in Bernese Mountain Dogs? Clinical signs of elbow dysplasia usually appear in puppies and young dogs, typically between 4 and 18 months of age. ### How is malignant histiocytosis definitively diagnosed in a Bernese Mountain Dog? A definitive diagnosis of malignant histiocytosis is made by a pathologist examining cells or tissue, obtained via a fine needle aspirate (FNA) or a biopsy, which reveals the characteristic malignant histiocytes. ### Can elbow dysplasia be cured? No, elbow dysplasia cannot be cured, but it can be managed. Treatment aims to slow the progression of secondary arthritis and manage pain, allowing the dog to live a comfortable life. ### Are Bernese Mountain Dogs more prone to hip dysplasia as well? Yes, Bernese Mountain Dogs have a high prevalence of hip dysplasia. One study found that 46% of Bernese Mountain Dogs examined at a Polish clinic were affected by the condition. ### What are the first signs of malignant histiocytosis that an owner might notice? The first signs are often vague and include lethargy, weight loss, decreased appetite, and sometimes coughing or difficulty breathing, which are due to the systemic spread of the cancer. ### What is the best exercise for a Bernese Mountain Dog with elbow dysplasia? Low-impact exercises like leash walks and swimming are best, as they help maintain muscle mass without putting excessive stress on the affected joint. ### Is there a genetic test for these diseases in Bernese Mountain Dogs? While the diseases have a strong genetic component, the approved sources do not mention a specific genetic test. Breeding decisions should be made in consultation with a veterinarian and breed clubs, focusing on screening for orthopedic diseases like hip and elbow dysplasia. ## Sources [1] [Factors affecting reproductive performance in the Swedish Bernese mountain dog.](https://pubmed.ncbi.nlm.nih.gov/36271408/) [2] [Canine hip dysplasia of selected breeds--results obtained by two Polish clinics based on radiological examination conducted in 1997-2006.](https://pubmed.ncbi.nlm.nih.gov/18683543/) [3] [Association between radiographic assessment of hip status and subsequent incidence of veterinary care and mortality related to hip dysplasia in insured Swedish dogs.](https://pubmed.ncbi.nlm.nih.gov/19819036/) ## Related Clinical & Scientific Guides * [Birman Health Problems: Inherited Conditions and Cardiac Screenings](/knowledge/veterinary-medicine/breed-specific-health/birman-health-problems-inherited-conditions-and-cardiac-screenings) * [Singapura Cat Health Problems: Inherited Conditions and Cardiac Screenings](/knowledge/veterinary-medicine/breed-specific-health/singapura-cat-health-problems-inherited-conditions-and-cardiac-screenings) * [Siberian Cat Health Problems: Inherited Conditions and Cardiac Screenings](/knowledge/veterinary-medicine/breed-specific-health/siberian-cat-health-problems-inherited-conditions-and-cardiac-screenings)